Trademark: 79328332
Status Date
Tuesday, October 11, 2022
Registration Number
6868480
Registration Date
Tuesday, October 11, 2022
Filing Date
Wednesday, November 3, 2021
Published for Opposition
Tuesday, July 26, 2022
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
The mark consists of a three-dimensional partially rounded band with concave ends tilted down and to the right partially encircling ten, variously sized circles that diminish in size and extend down and to the right through the opening in the band; the largest innermost circle is three dimensional and has a circle on its upper right quadrant, the second largest circle is three-dimensional and is separated from the largest cirlcle by three smaller circles, the third largest circle is separated from the second largest circle by the three smallest circles; the color grey is intended to show shading or contrast only and is not a feature of the mark.
Feb 21, 2023
Final Decision Transaction Processed By Ib
Feb 2, 2023
Final Disposition Notice Sent To Ib
Feb 1, 2023
Final Disposition Processed
Jan 11, 2023
Final Disposition Notice Created, To Be Sent To Ib
Oct 11, 2022
Notice Of Registration Confirmation Emailed
Oct 11, 2022
Registered-Principal Register
Jul 26, 2022
Notification Processed By Ib
Jul 26, 2022
Official Gazette Publication Confirmation E-Mailed
Jul 26, 2022
Published For Opposition
Jul 6, 2022
Notification Of Possible Opposition Sent To Ib
Jul 6, 2022
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jul 6, 2022
Notification Of Notice Of Publication E-Mailed
Jun 21, 2022
Approved For Pub - Principal Register
Jun 6, 2022
Assigned To Examiner
May 23, 2022
Teas/Email Correspondence Entered
May 23, 2022
Correspondence Received In Law Office
May 23, 2022
Teas Response To Office Action Received
May 1, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
May 1, 2022
Teas Change Of Correspondence Received
May 1, 2022
Teas Change Of Domestic Representatives Address
May 1, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
May 1, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 1, 2022
Teas Change Of Owner Address Received
Mar 27, 2022
Refusal Processed By Ib
Mar 8, 2022
Non-Final Action Mailed - Refusal Sent To Ib
Mar 7, 2022
Refusal Processed By Mpu
Feb 9, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Feb 8, 2022
Non-Final Action Written
Feb 7, 2022
Assigned To Examiner
Jan 4, 2022
Application Filing Receipt Mailed
Dec 30, 2021
New Application Office Supplied Data Entered
Dec 27, 2021
Limitation From Original Application Entered
Dec 16, 2021
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
